Search Sciety

Showing page 2 of 776 pages of search results

• Which innovations can improve timeliness of investigations and address the backlog in endoscopy for patients with potential symptoms of upper and lower Gastrointestinal (GI) cancers?

  This article's authors

  1. Hendry A
  2. Spencer LH
  3. Hartfiel N
  4. Anthony B
  5. Roberts J
  6. Charles JM
  7. Bray N
  8. Wilkinson C
  9. Edwards RT

• Correlation of Suspected COVID-19 Symptoms with COVID-19 Positivity in Children

  This article's authors

  1. Satoskar SA
  2. Hindman D
  3. Husain A
  4. Prichett L
  5. Badaki OB
  6. Kane A

• Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2

  This article's authors

  1. Halliday A
  2. Long AE
  3. Baum HE
  4. Thomas AC
  5. Shelley KL
  6. Oliver E
  7. Gupta K
  8. Francis O
  9. Williamson MK
  10. di Bartolo N
  11. Randell MJ
  12. Ben-Khoud Y
  13. Kelland I
  14. Mortimer G
  15. Ball O
  16. Plumptre C
  17. Chandler K
  18. Obst U
  19. Secchi M
  20. Piemonti L
  21. Lampasona V
  22. Smith J
  23. Gregorova M
  24. Knezevic L
  25. Metz J
  26. Barr R
  27. Morales-Aza B
  28. Oliver J
  29. Collingwood L
  30. Hitchings B
  31. Ring S
  32. Wooldridge L
  33. Rivino L
  34. Timpson N
  35. McKernon J
  36. Muir P
  37. Hamilton F
  38. Arnold D
  39. Woolfson DN
  40. Goenka A
  41. Davidson AD
  42. Toye AM
  43. Berger I
  44. Bailey M
  45. Gillespie KM
  46. Williams AJ
  47. Finn A

• Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel

  This article's authors

  1. Tene L
  2. Chodick G
  3. Fallach N
  4. Ansari W
  5. Distelman-Menachem T
  6. Maor Y

• Comparative analysis of the outcomes of COVID-19 between patients infected with SARS-CoV-2 Omicron and Delta variants: a retrospective cohort study

  This article's authors

  1. Gunadi
  2. Hakim MS
  3. Wibawa H
  4. Vujira KA
  5. Puspitarani DA
  6. Supriyati E
  7. Trisnawati I
  8. Iskandar K
  9. Khair RE
  10. Afiahayati
  11. Siswanto
  12. Puspadewi Y
  13. Irene
  14. Irianingsih SH
  15. Daniwijaya EW
  16. Agung Nugrahaningsih DA
  17. Gabriela GC
  18. Geometri ET
  19. Eryvinka LS
  20. Trie Utami FD
  21. Devana EM
  22. Aditama L
  23. Putri Kinasih NC
  24. Amadeus VC
  25. Hediningsih Y
  26. Ananda NR
  27. Arguni E
  28. Nuryastuti T
  29. Wibawa T

• An Early Return-to-Work Program for COVID-19 Close Contacts in Healthcare During the Omicron Wave in Japan

  This article's authors

  1. Naruse H
  2. Doi Y
  3. Iwata M
  4. Ishikawa K

• Population-based Oral Cancer Service Screening Disrupted by COVID-19 Pandemic: Observational and Simulation Study

  This article's authors

  1. Su C
  2. Liu Y
  3. Yen AM
  4. Chiu H
  5. Chen TH
  6. Hsu T
  7. Shih M
  8. Su WW
  9. Chen SL

• Spatiotemporal landscape of SARS-CoV-2 pulmonary infection reveals Slamf9⁺Spp1⁺ macrophages promoting viral clearance and inflammation resolution

  This article's authors

  1. Cong B
  2. Dong X
  3. Yang Z
  4. Yu P
  5. Chai Y
  6. Liu J
  7. Zhang M
  8. Zang Y
  9. Kang J
  10. Feng Y
  11. Liu Y
  12. Feng W
  13. Deng W
  14. Li F
  15. Yu Q
  16. Gu Y
  17. Li Z
  18. Liu S
  19. Xu X
  20. Zhong N
  21. Ren X
  22. Qin C
  23. Liu L
  24. Wang J
  25. Cao X

• Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments

  This article's authors

  1. Gleeson S
  2. Martin P
  3. Thomson T
  4. Thind A
  5. Prendecki M
  6. Spensley KJ
  7. Clarke CL
  8. Roufosse C
  9. Pickard G
  10. Thomas D
  11. McAdoo SP
  12. Lightstone L
  13. Kelleher P
  14. Willicombe M

• SOFA score performs worse than age for predicting mortality in patients with COVID-19

  This article's authors

  1. Sherak RAG
  2. Sajjadi H
  3. Khimani N
  4. Tolchin B
  5. Jubanyik K
  6. Andrew Taylor R
  7. Schulz W
  8. Mortazavi BJ
  9. Haimovich AD

• SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation

  This article's authors

  1. Jonker L
  2. Linde KJ
  3. de Hoog ML
  4. Sprado R
  5. Huisman RC
  6. Molenkamp R
  7. Oude Munnink BB
  8. Dohmen W
  9. Heederik DJ
  10. Eggink D
  11. Welkers MR
  12. Vennema H
  13. Fraaij PL
  14. Koopmans MP
  15. Wouters IM
  16. Bruijning-Verhagen PC

• Protection from Omicron and other VOCs by Bivalent S-Trimer COVID-19 Vaccine

  This article's authors

  1. Su D
  2. Li X
  3. Huang X
  4. He C
  5. Zeng C
  6. Wang Q
  7. Qin W
  8. Mu Z
  9. Ambrosino D
  10. Siber G
  11. Clemens R
  12. Liang JG
  13. Liang P
  14. Jackson N
  15. Xu R

• Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

  This article's authors

  1. Vargas-Herrera N
  2. Fernández-Navarro M
  3. Cabezudo NE
  4. Soto-Becerra P
  5. Solís-Sánchez G
  6. Escobar-Agreda S
  7. Silva-Valencia J
  8. Pampa-Espinoza L
  9. Bado-Pérez R
  10. Solari L
  11. Araujo-Castillo RV

• Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages

  This article's authors

  1. Tegally H
  2. Moir M
  3. Everatt J
  4. Giovanetti M
  5. Scheepers C
  6. Wilkinson E
  7. Subramoney K
  8. Moyo S
  9. Amoako DG
  10. Baxter C
  11. Althaus CL
  12. Anyaneji UJ
  13. Kekana D
  14. Viana R
  15. Giandhari J
  16. Lessells RJ
  17. Maponga T
  18. Maruapula D
  19. Choga W
  20. Matshaba M
  21. Mayaphi S
  22. Mbhele N
  23. Mbulawa MB
  24. Msomi N
  25. Naidoo Y
  26. Pillay S
  27. Sanko TJ
  28. San JE
  29. Scott L
  30. Singh L
  31. Magini NA
  32. Smith-Lawrence P
  33. Stevens W
  34. Dor G
  35. Tshiabuila D
  36. Wolter N
  37. Preiser W
  38. Treurnicht FK
  39. Venter M
  40. Davids M
  41. Chiloane G
  42. Mendes A
  43. McIntyre C
  44. O’Toole A
  45. Ruis C
  46. Peacock TP
  47. Roemer C
  48. Williamson C
  49. Pybus OG
  50. Bhiman J
  51. Glass A
  52. Martin DP
  53. Rambaut A
  54. Gaseitsiwe S
  55. Gottberg Av
  56. de Oliveira T
  57. NGS-SA consortium

• Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals

  This article's authors

  1. Stokes W
  2. Venner AA
  3. Buss E
  4. Tipples G
  5. Berenger BM

• Effectiveness of Covid-19 vaccines against SARS-CoV-2 Omicron variant (B.1.1.529): A systematic review with meta-analysis and meta-regression

  This article's authors

  1. Pratama NR
  2. Wafa IA
  3. Budi DS
  4. Sutanto H
  5. Asmarawati TP
  6. Wungu CDK

• Keeping it close: The role of a Campus COVID Support Team (CCST) in sustaining a safe and healthy university campus during COVID-19

  This article's authors

  1. McDonnell KA
  2. Vyas A
  3. Castel A
  4. Nagaraj N
  5. Landry M

• Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study

  This article's authors

  1. Bartelt LA
  2. Markmann AJ
  3. Nelson B
  4. Keys J
  5. Root H
  6. Henderson HI
  7. Kuruc J
  8. Baker C
  9. Bhowmik DR
  10. Hou YJ
  11. Premkumar L
  12. Cornaby C
  13. Schmitz JL
  14. Weiss S
  15. Park Y
  16. Baric R
  17. de Silva AM
  18. Lachiewicz A
  19. Napravnik S
  20. van Duin D
  21. Margolis DM

• Epidemiological and clinical features of SARS-CoV-2 Infection in children during the outbreak of Omicron Variant in Shanghai, March 7-March 31, 2022

  This article's authors

  1. Wang X
  2. Chang H
  3. Tian H
  4. Li J
  5. Wei Z
  6. Wang Y
  7. Xia A
  8. Ge Y
  9. Wang J
  10. Liu G
  11. Cai J
  12. Wang J
  13. Zhu Q
  14. Zhu Y
  15. Zhai X
  16. Zeng M

• Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence

  This article's authors

  1. Gisby JS
  2. Buang NB
  3. Papadaki A
  4. Clarke CL
  5. Malik TH
  6. Medjeral-Thomas N
  7. Pinheiro D
  8. Mortimer PM
  9. Lewis S
  10. Sandhu E
  11. McAdoo SP
  12. Prendecki MF
  13. Willicombe M
  14. Pickering MC
  15. Botto M
  16. Thomas DC
  17. Peters JE